Facile preparation of cyclic oligoribonucleotides. by DE NAPOLI, Lorenzo et al.
J.  CHEM. soc. PERKIN TRANS. I 1993 747 
Facile Preparation of Cyclic Oligoribonucleotides 
L. De Napoli,8 A. Galeone8b L. MayoLb A. Messere,8 G. Piccialli * e 8  and 
C. Santacrocea 
a Dipartimento di Chimica Organica e Biologica, Universita ' di Napoli 'Federico I/ ', via Mezzocannone 16, 
80134 Napoli, Italy 
Dipartimento di Chimica delle Sostanze Naturali, Universita 'di Napoli 'Federico 11; via 0. Montesano 49, 
80131 Napoli, Italy 
A convenient solid-phase synthesis of small cyclic oligoribonucleotides based on elongation of 
the chain by phosphoramidite chemistry, and successive cyclization of the linear fragments by a 
phosphotriester approach is described. 
The potential of cyclic oligodeoxyribonucleotides (cODNs) and 
cyclic oligoribonucleotides (CORNS) in a variety of biological 
connections -3 justifies work on improving their synthesis. 
Whilst both solid phase4 and solution' methods have been 
described for the preparation of cODNs, for CORNS the only 
available procedure is based on a modified phosphotriester 
approach in ~olution.~" Here we report the first solid-phase 
synthesis of small cyclic RNAs. Previously we have described a 
number of solid supports for the synthesis of cODNs evaluating 
the cyclization yields on the basis of the linear precursors still 
anchored to the support through the exocyclic amino function 
of a base r e s i d ~ e . ~  In this work we found that decreasing yields 
accompanied increasing size of the starting linear oligomers, 
steric factors affecting the intermolecular couplings and, further, 
that, with an equal number of residues, the highest product 
yields were obtained with a polyacrylamide resin solid support. 
Unfortunately, such a resin is not only incompatible with 
phosphoramidite chemistry but its poor mechanical properties 
preclude its use in an automated process. Chain elongation for 
synthesis of the linear precursor on polyacrylamide resin must 
be performed, therefore, by a manual process based on 
phosphotriester chemistry, whose relatively low efficiency (ca. 
92% average yield per cycle), limits the size of cODNs of mixed 
sequences which can be prepared. Recently we have found that 
a copolymer of polyethylene glycol and polystyrene (PEG-PS, 
commercially known as Tentage16) is a suitable solid support 
for an efficient and completely automated synthesis of mixed 
sequences of cODNs containing up to 12 residues.' The 
observed lower cyclization yields, in comparison with the 
polyacrylamide resin, are balanced by the compatibility of 
Tentage1 with DNA synthesizers and with phosphoramidite 
chemistry which ensures higher final yields of the linear 
precursor through a standard, fully automated, process. 
Here we describe the successful synthesis of cyclic homo- 
oligomers of cytidine containing up to 8 residues using Tentagel 
as solid support. The most attractive feature of this approach 
for the synthesis of CORNS is that both the elongation process 
(via phosphoramidite chemistry) and the cyclization reaction 
(via phosphotriester chemistry) are performed on the solid 
support thus avoiding the unconvenience associated with the 
syntheses in solution. 
The preparative route for CORNS is outlined in Schemes 1 
and 2 and consists of the following: (a) synthesis of the 
intermediate 2, useful for the preparation of the building block 
3 and of the phosphotriester intermediate 6: (b) incorporation 
of 6 into the resin 8 thus obtaining the functionalizd support 9; 
(c) elongation of the chain; (d) removal of the protecting groups 
from both the ends of the chain and cyclization; (e) detachment 
of the cyclic ORNs from the resin and deprotection. The 
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Scheme 1 Reagent and conditions: i ,  DMT-CI, pyridine, 10 h (90%); ii ,  
TBDMSi-Cl, AgNO,, pyridine, 6 h (65%); iii, MeOPr',NPCI, di- 
methylaminopyridine, EtNPr',, THF, 3 h (85%); iv, CIC,H,OPOCl,, 
pyridine, 0 "C, 1 h (84%); v, aq. NH, (32%)/EtOH (3:  I ) ,  55 "C, 2 h 
(89%); vi, HOCEt, MSNT, pyridine, 3 h (60%) 
intermediate 2 was obtained from N4-benzoylcytidine 1 which 
was protected as a 5'-dimethoxytrityl derivative and, succes- 
sively, 2'-silylated as previously described.* 3'-Phosphitylation 
of 2, with N,N-diisopropylmethylphosphonamidic chloride, by 
a standard method afforded the phosphoramidite inter- 
mediate 3. Treatment of 2 with 2-chlorophenyl phosphoro- 
dichloridate gave the phosphodiester derivative 4 which under- 
went debenzoylation, using aq. NH, (32%) in EtOH, and was 
then fully protected at  the 3'-phosphate by reaction with p- 
hydroxypropionitrile (HOCEt) and mesitylenesulfonyl-3-nitro- 
1,2,4-triazole (MSNT) in pyridine to yield the intermediate 6. 
The PEG-PS 7 (0.24 mequiv. g-' of amino groups) was 
prefunctionalized 4b with succinic anhydride, thus giving 8 
which was then treated with a solution of 6 in pyridine in the 
presence of N,N'-dicyclohexylcarbodiimide (DCCI). The incor- 
poration of the nucleotidic material was in the range 0.1 CO. 14 
mequiv. g-' , as estimated by quantitative spectroscopic 
measurement of the 4,4'-dimethoxytriphenylmethyl (DMT) 
cation released from resin 9. The support 9 was used for the 
preparation of linear homooligomers of cytidine (tetramer, 
hexamer and octamer) by standard phosphoramidite (OMe) 
chemistry l o  on an automated synthesizer. In order to allow the 
cyclization of the linear fragments, 10 was deprotected at both 
ends by treatment with dichloroaceticacid (DCA; 3% in CH,Cl,) 
followed by reaction with triethylamine-pyridine (1  : 1 ) .  Suc- 
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Scheme 2 Reagent and conditions: i, succinic anhydride, pyridine 16 h; 
ii, 6 (2.5 equiv.), DCCI (10 equiv.), pyridine 16 h; iii, ref. 10; iv, DCA, 
CH,CI, (5 rnin); v, Et,N/pyridine ( I  : I ) ,  0.5 h; vi, MSNT, pyridine, 12 h; 
vii, PhSH/Et,N/dioxane (1 : 2 : 2), 1 h; viii, aq. NH, (32%)/EtOH (3 : I ) ,  
4 h, 55 OC; ix, Bu,NF, THF 
with the resin for 12 h. This cyclization time assured complete 
disappearance of the linear precursors, as judged by HPLC 
profiles. The cyclic oligomers were removed from the resin and 
deprotected in three steps (vii-ix, Scheme 2). The completely 
deblocked cyclic oligomers were purified by ion exchange 
HPLC. The results of analyses of the products allowed the 
cyclization yields to be calculated; these were 40% (tetramer), 
38% (hexamer) and 28% (octamer). It is to be noted that the 
decreasing trend of the cyclic yields on increasing the size of the 
oligomers matches that observed in the cyclization of deoxy- 
oligomers. After desalting, the products were analysed by 
'H NMR spectrscopy which established their cyclic nature, 
showing the complete equivalence of each nucleotide (one signal 
for each type of nucleus was observed). 
In conclusion, Tentage1 has been shown to be a suitable 
polymeric support for a completely automated solid-phase 
synthesis of small RNA cyclic compounds. Furthermore, the 
coupling yields observed ( > 98%) in conjunction with short 
reaction time (2 min) in the chain elongation steps, suggest that 
this support is a valid alternative to the widely used controlled 
pore glass (CPG) resin for the synthesis of linear ORNs; further, 
it results in a two-three fold higher degree of functionalization 
for Tentagel over CPG. 
Experimental 
Synthesis of Intermediate 3.-Compound 2 was converted 
into the phosphoramidite 3 essentially as previously reported.' 
Purification was performed by HPLC using a silica gel column 
(Merck, LiChrosorb Si 60, 25 mm i.d.) eluted with increasing 
amounts (0-100%) of AcOEt in hexane, flow rate 13 cm3 min 
The fraction eluted with AcOEt afforded pure 3 (as a dia- 
stereoisomeric mixture) the structure for which was confirmed 
on the basis of NMR data. 
Synthesis of Intermediate 6.-A solution of 2-chlorophenyl 
phosphorodichloridate (0.7 cm3, 4 mmol) in pyridine (4 cm3), 
was added to a stirred solution of 2 (380 mg, 0.5 mmol) in 
pyridine (5 cm3) at 0 "C. After 40 min the mixture was diluted 
with water (1 cm3) and then concentrated. The residue was 
dissolved in CHCl, and the solution washed with water ( x 3). 
The organic layer was separated, concentrated and purified on 
a silica gel column eluting with increasing amounts of MeOH in 
CHCl, (5-20%) to give pure 4 (84%). The latter was treated 
with aq. NH, (32%)/EtOH (3: l ) ,  2.5 h, 50 OC, to afford the 
debenzoylated crude product 5 (90%). After purification 
(essentially as above), to a solution of 5 (340 mg, 0.4 mmol) in 
pyridine (5 cm3), was added HOCEt (284 mg, 4 mmol) and then 
MSNT (474 mg, 1.6 mmol). After 2 h, water (2 cm3) was added 
to the mixture which was then concentrated. The residue was 
dissolved in CHCI, (15 cm3) and the solution washed with 
water ( x 3), taken to dryness and finally purified on a silica gel 
column using increasing amounts of MeOH in CHCI, (0-5%), 
to afford pure 6 (60%), the structure of which (mixture of 
diastereoisomers) was confirmed by NMR data. 
Chain Assembly and Cyclization on Solid Support.-Syntheses 
were performed using support 8 according to the phosphor- 
amidite method by a Beckman 200A automatic synthesizer. The 
steps utilized for each cycle have already been described in the 
literature. l o  For a coupling reaction with intermediate 3 we 
used a longer time (30 min). After deprotection of 10 at both 
ends (steps iv-v, Scheme 2) and washing with pyridine, a 
solution of 0.2 mol of MSNT in pyridine was left in contact with 
the resin, 12 h, room temp. After washing with pyridine and 
MeCN, the final support was dried under reduced pressure. 
Deprotection and Purification of Cyclic 0ligomers.-Detach- 
ment and deprotection of cyclic oligomers were performed as 
previously described.' HPLC analyses, purifications, and 
desalting of the linear and cyclic products were carried out as 
previously reported.4"- In the synthesis of cyclic octamer 
c-[pCp(Cp),C] starting from 50 mg (6 pmol) of 8, 2.2 mg (0.9 
pmol, 15% overall yield) of the isolated product was obtained; 
SH(400 Mz, D,O, protons at  lowfield region) 7.42 (8 H, d, J 3.2, 
1'-H); 5.56 (8 H, d, J 7.0, 5-H) and 5.45 (8 H, d, J 3.2, 2'-H). 
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